Crossmark

Deficiency in NPC2 results in disruption of mitochondria-late endosome/lysosomes contact sites and endo-lysosomal lipid dyshomeostasis

Published Online: 2025-01-02

Authors

Pastore, Raffaele

Yao, Lihang

Hatcher, Nathan

Helley, Martin

Brownlees, Janet

Desai, Radha
License Information

Text and Data Mining valid from 2025-01-02

Version of Record valid from 2025-01-02
More Information

Article History

Received: 25 March 2024

Accepted: 16 December 2024

First Online: 2 January 2025

Declarations

:

: Authors are employees of Merck Sharp & Dohme Corp., a subsidiary of Merck & Co., Inc., Kenilworth, NJ, USA and may hold stocks and/or stock options in Merck & Co., Inc., Kenilworth, NJ, USA.

Document is current